Articles

NMPA Accelerated Approval Pathway: Impact on China's Innovative Drug Market

The NMPA Accelerated Approval Pathway is transforming China's innovative drug market, expediting access to essential cancer therapies and fostering innovation.

NMPA Expedited Approval Oncology: Impact on Cancer Drug Access in China

The NMPA's expedited approval process is transforming cancer drug access in China, significantly impacting treatments like osimertinib for lung cancer patients.

AI in Drug Discovery Japan: What You Need to Know

Discover the impact of AI on drug discovery in Japan, highlighting advancements in treatments such as Ozanimod for multiple sclerosis and their implications.